The Trends in Travel™. The annual global report highlights shifts in traveller behaviour and the destinations set to dominate ...
Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...
Every time Adam publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...